Your Patients Can't Find Their Inhaler — Here's How You Can Help

When patients call your office saying they can't fill their Fluticasone/Vilanterol (Breo Ellipta) prescription, it creates a clinical problem. Gaps in maintenance ICS/LABA therapy increase the risk of asthma exacerbations and COPD flare-ups. As a provider, you're in a unique position to help patients navigate these availability challenges proactively.

This guide outlines practical steps you and your care team can take to keep patients on therapy when pharmacy stock is an issue.

Current Availability of Fluticasone/Vilanterol

As of early 2026, Fluticasone/Vilanterol is not in an FDA-listed shortage. GlaxoSmithKline (GSK) continues to manufacture both the brand-name Breo Ellipta and its authorized generic. National wholesale supply appears adequate.

However, retail-level stock-outs remain a common patient complaint. The gap between wholesale availability and retail shelf stock is driven by:

• Pharmacy ordering cycles that don't always match patient demand
• Seasonal spikes in respiratory medication fills
• Chain pharmacy inventory management systems that prioritize high-volume generics
• High unit cost ($350-$450 brand; $250-$350 generic) discouraging pharmacies from stocking extra units

For a detailed analysis, see our provider briefing: Fluticasone/Vilanterol Shortage: What Providers Need to Know.

Why Patients Can't Find It

Understanding the patient experience helps you respond effectively. Here's what patients typically encounter:

• "We don't have it in stock" — The pharmacy doesn't carry it or has run out. They may offer to order it (1-3 day wait) or suggest the patient try elsewhere.
• "Your insurance requires prior authorization" — The prescription is on hold pending PA approval, and the patient doesn't understand why they can't just get it.
• "The copay is too high" — The patient can't afford the Tier 3 or Tier 4 copay, so the prescription goes unfilled.
• "We have the generic but not the brand" — If the prescription specifies DAW-1, the pharmacy can't substitute the authorized generic.

Each of these scenarios has a solution — and most of them start in your office.

What Providers Can Do: 5 Practical Steps

Step 1: Check Stock Before You Prescribe

Use Medfinder for Providers to check which pharmacies near your patient have Fluticasone/Vilanterol in stock. Then send the prescription to a pharmacy that has it. This one step can eliminate the most common patient complaint.

Step 2: Allow Generic Substitution

When writing the prescription, ensure it permits generic substitution (DAW-0). The authorized generic of Breo Ellipta is the same medication in the same Ellipta device, manufactured by the same company. Allowing substitution doubles the chance a pharmacy can fill it immediately.

Step 3: Complete Prior Authorizations Proactively

If you know a patient's insurance plan requires prior authorization for Fluticasone/Vilanterol, initiate the PA process at the time of prescribing — not after the patient gets rejected at the pharmacy. Many EHR systems allow electronic PA submission. Consider designating a staff member to handle PA workflows for respiratory medications.

Step 4: Provide Cost-Saving Resources

For patients struggling with cost, equip them with options:

• GSK Savings Card: Commercially insured patients may pay as little as $10
• GSK Patient Assistance Program: Free medication for qualifying uninsured/underinsured patients (household income ≤300% FPL). Apply at GSKForYou.com or call 1-888-825-5249.
• Pharmacy discount cards: Services like GoodRx, SingleCare, and RxSaver can reduce out-of-pocket costs for uninsured patients
• Mail-order pharmacy: Often provides 90-day supplies at lower per-unit cost

Share our patient-facing cost guide: How to Save Money on Fluticasone/Vilanterol in 2026.

Step 5: Have a Backup Plan Ready

For patients with a history of difficulty filling Fluticasone/Vilanterol, consider proactively discussing alternatives so they aren't left without medication if another stock-out occurs. Appropriate alternatives include:

• Budesonide/Formoterol (Symbicort) — Widely available, approved for asthma and COPD, twice-daily MDI
• Fluticasone/Salmeterol (Advair or generics) — Established ICS/LABA, generics available at $150-$250, twice-daily
• Mometasone/Formoterol (Dulera) — Asthma only, twice-daily MDI

Document the conversation so that if the patient calls unable to fill, your office can quickly send an alternative prescription without requiring a full office visit.

Alternative Medications at a Glance

Here's a quick reference for therapeutic alternatives:

• Symbicort (Budesonide/Formoterol) — ICS/LABA, MDI, twice daily. Asthma + COPD. Often formulary-preferred.
• Advair Diskus/HFA (Fluticasone/Salmeterol) — ICS/LABA, DPI or MDI, twice daily. Asthma + COPD. Generics (Wixela Inhub, AirDuo) at $150-$250.
• Dulera (Mometasone/Formoterol) — ICS/LABA, MDI, twice daily. Asthma only.
• Trelegy Ellipta (Fluticasone/Umeclidinium/Vilanterol) — ICS/LAMA/LABA triple, DPI, once daily. COPD + asthma. Same Ellipta device. Consider for COPD patients who may benefit from step-up.

For the patient-facing version: Alternatives to Fluticasone/Vilanterol.

Workflow Tips for Your Practice

Integrating availability awareness into your prescribing workflow doesn't have to be complicated:

• Bookmark Medfinder for Providers for quick stock checks during patient visits
• Train front-desk and nursing staff on how to help patients who call about unfilled prescriptions — a simple stock check and prescription redirect can resolve most cases
• Build a respiratory formulary cheat sheet listing your preferred ICS/LABA alternatives with dose equivalencies, device types, and typical insurance tier positions
• Flag high-risk patients — Patients with frequent exacerbations or multiple ED visits should have backup prescriptions on file
• Use e-prescribing to your advantage — Some e-prescribing platforms show real-time pharmacy inventory. Check if yours supports this feature.

Final Thoughts

Medication availability isn't just a pharmacy problem — it's a clinical continuity problem. When patients can't fill their Fluticasone/Vilanterol prescription, the risk of exacerbations, ED visits, and hospitalizations increases. By building simple availability checks and cost conversations into your workflow, you can significantly reduce these disruptions.

Tools like Medfinder for Providers make this easier than ever. A few minutes at the point of prescribing can save your patients hours of frustration and keep them on the therapy they need.

For more provider resources, see: How to Help Patients Save Money on Fluticasone/Vilanterol.